[{"Assets_0_Q3_USD":282319000.0,"CommonStockSharesOutstanding_0_Q3_shares":40381854.0,"NetIncomeLoss_1_Q3_USD":-24707000.0,"NetIncomeLoss_3_Q3_USD":-68498000.0,"StockholdersEquity_0_Q3_USD":178958000.0,"Ticker":"CRSP","CIK":"1674416","name":"CRISPR THERAPEUTICS AG","OfficialName":"CRISPR Therapeutics AG Common Shares","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"4543904930.0","Country":"Switzerland","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20171108"}]